the coinfected group (8%), although this difference did not reach statistical significance (p=0.06); Fig. 3 A,C.
← all excerpts
Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort.
1
0.0600
0.0600
the coinfected group (8%), although this difference did not reach statistical significance (p=0.06); Fig. 3 A,C.